DrugDevice Combination Product A therapeutic system combining a physical device (MN patch) with an active drug, requiring coordinated regulatory oversight
Exposure to omega-3 fatty acids at early age accelerate bone growth and improve bone quality
Perhaps the more significant issue is the question of sequencing
Since the use of animal insulin for the treatment of diabetes in 1922, about nine major classes of drugs for the treatment of diabetes have been discovered and developed worldwide, including sulfonylureas, biguanides, -glucosidase inhibitors, insulins, thiazolidinediones (TZDs), meglitinides, GLP-1RAs, DPP-4 inhibitors, and SGLT-2 inhibitors
Reference: Willard FS et al
"The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies"